Non-Interventional Centers for Stroke (ALERT Trial)

N/A

Waitlist Available

Led By Jason Tarpley, M.D., Ph. D.

Research Sponsored by Providence Little Company of Mary-Torrance

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time of subject presentation through up to 90 days post treatment.

Awards & highlights

Summary

Post Market, Prospective, Randomized, Controlled, multi center data collection study to evaluate the use of Viz versus the standard of care in stroke workflow and clinical outcome parameters.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time of subject presentation through up to 90 days post treatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time of subject presentation through up to 90 days post treatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and time of subject presentation through up to 90 days post treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interventional Centers

Non-Interventional Centers

Secondary outcome measures

Workflow Endpoints

Trial Design

2Treatment groups

Experimental Treatment

Group I: Non-Interventional CentersExperimental Treatment1 Intervention

Cohort A: Viz Subjects Initially Presenting to a Non-Interventional Center The group will be comprised of subjects randomized to Viz and who initially present to a non- interventional center. Cohort B: Subjects Initially Presenting to a Non-Interventional Center The standard of care group will be comprised of subjects randomized to not have Viz notification and who initially present to a non-interventional center.

Group II: Interventional CentersExperimental Treatment1 Intervention

Cohort C: Viz Subjects Initially Presenting to an Interventional Center The group will be comprised of subjects randomized to Viz and who initially present to a interventional center. Cohort D: Subjects Initially Presenting to a Interventional Center The standard of group will be comprised of subjects randomized to not have Viz notification and who initially present to an interventional center.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Viz.ai, Inc.Industry Sponsor

3 Previous Clinical Trials

6,500 Total Patients Enrolled

Providence Little Company of Mary-TorranceLead Sponsor

Jason Tarpley, M.D., Ph. D.Principal InvestigatorProvidence Little Company of Mary Medical Center-Torrance

~87 spots leftby Sep 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.